Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Tuesday.
The Dow traded up 0.24% to 33,710.06 while the NASDAQ fell 0.21% to 11,340.24. The S&P 500 also fell, dropping, 0.11% to 4,015.51.
Gainers
Baudax Bio, Inc. (NASDAQ: BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery.
U.S. stocks traded mostly flat midway through trading, with the Dow Jones trading slightly higher on Tuesday.
The Dow traded up 0.03% to 33,638.42 while the NASDAQ fell 0.07% to 11,356.65. The S&P 500 also fell, dropping, 0.09% to 4,016.08.
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday.
The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The S&P 500 also rose, gaining, 0.85% to 4,006.43.
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 30 points on Monday.
The Dow traded up 0.94% to 33,687.69 while the NASDAQ rose 1.93% to 11,355.16. The S&P 500 also rose, gaining, 1.31% to 4,024.60.
Verb Technology Company Inc (NASDAQ: VERB) shares are up more than 100% Monday after the company announced its board of directors has begun examining measures to address the alleged illegal short selling of its stock, among other